Literature DB >> 26065323

Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.

F Shirazi1, D P Kontoyiannis.   

Abstract

Candida biofilms play an important role in infections associated with medical devices and are resistant to antifungals. We hypothesized that the echinocandin micafungin (MICA) exerts an enhanced antifungal activity against caspofungin (CAS)-susceptible (CAS-S) and CAS-non-susceptible (CAS-NS) Candida albicans and Candida parapsilosis which is at least in part through apoptosis, even in the biofilm environment. Apoptosis was characterized by detecting reactive oxygen species (ROS) accumulation, depolarization of mitochondrial membrane potential (MMP), DNA fragmentation, lack of plasma membrane integrity, and metacaspase activation following exposure of Candida biofilm to MICA for 3h at 37°C in RPMI 1640 medium. The minimum inhibitory concentration was higher for CAS (2.0-16.0 μg/mL) than for MICA (1.0-8.0 μg/mL) for Candida biofilms. Elevated intracellular ROS levels and depolarization of MMP was evident in CAS-S C. albicans (3.0-4.2 fold) and C. parapsilosis (4.8-5.4 fold) biofilms compared with CAS-NS (1.2 fold) after exposure to MICA (0.25x-1xMIC). Elevated intracellular ROS levels and depolarization of MMP was evident in CAS-S C. albicans (3.0-4.2 fold) and C. parapsilosis (4.8-5.4 fold) biofilms compared with CAS-NS (1.2 fold) after exposure to MICA (0.25x-1xMIC). Finally higher ß-1, 3 glucan levels were seen in sessile cells compared to planktonic cells, especially in CAS-NS strains. MICA treatment might induce a metacaspase-dependent apoptotic process in biofilms of both CAS-S C. albicans and C. parapsilosis, and to some degree in CAS-NS strains.

Entities:  

Keywords:  Apoptosis; biofilms; caspofungin; micafungin; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26065323      PMCID: PMC4601157          DOI: 10.1080/21505594.2015.1027479

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  29 in total

Review 1.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

Review 2.  Persister cells, dormancy and infectious disease.

Authors:  Kim Lewis
Journal:  Nat Rev Microbiol       Date:  2006-12-04       Impact factor: 60.633

Review 3.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  A caspase-related protease regulates apoptosis in yeast.

Authors:  Frank Madeo; Eva Herker; Corinna Maldener; Silke Wissing; Stephan Lächelt; Mark Herlan; Markus Fehr; Kirsten Lauber; Stephan J Sigrist; Sebastian Wesselborg; Kai Uwe Fröhlich
Journal:  Mol Cell       Date:  2002-04       Impact factor: 17.970

Review 5.  Programmed death in bacteria.

Authors:  K Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

Review 6.  Apoptosis in yeast.

Authors:  Frank Madeo; Eva Herker; Silke Wissing; Helmut Jungwirth; Tobias Eisenberg; Kai-Uwe Fröhlich
Journal:  Curr Opin Microbiol       Date:  2004-12       Impact factor: 7.934

Review 7.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 8.  Candida biofilms and their role in infection.

Authors:  L Julia Douglas
Journal:  Trends Microbiol       Date:  2003-01       Impact factor: 17.079

9.  Apoptosis induced by environmental stresses and amphotericin B in Candida albicans.

Authors:  Andrew J Phillips; Ian Sudbery; Mark Ramsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  Purpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilms.

Authors:  Paul Wai-Kei Tsang; Alan Pak-Kin Wong; Hai-Ping Yang; Ngai-For Li
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more
  10 in total

1.  Activity of Sanguinarine against Candida albicans Biofilms.

Authors:  Hua Zhong; Dan-Dan Hu; Gan-Hai Hu; Juan Su; Shuang Bi; Zhuo-Er Zhang; Zheng Wang; Ri-Li Zhang; Zheng Xu; Yuan-Ying Jiang; Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans.

Authors:  Xueqi Chen; Jiyong Wu; Lei Sun; Jing Nie; Shan Su; Shujuan Sun
Journal:  Drug Des Devel Ther       Date:  2021-11-16       Impact factor: 4.162

Review 3.  Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.

Authors:  Francine Perrine-Walker
Journal:  Braz J Microbiol       Date:  2022-03-29       Impact factor: 2.214

4.  In Vitro and In Silico Analysis of Ascorbic Acid Towards Lanosterol 14-α-Demethylase Enzyme of Fluconazole-Resistant Candida albicans.

Authors:  Arumugam Ganeshkumar; Suvaiyarasan Suvaithenamudhan; Rajendran Rajaram
Journal:  Curr Microbiol       Date:  2020-11-10       Impact factor: 2.188

Review 5.  Guidelines and recommendations on yeast cell death nomenclature.

Authors:  Didac Carmona-Gutierrez; Maria Anna Bauer; Andreas Zimmermann; Andrés Aguilera; Nicanor Austriaco; Kathryn Ayscough; Rena Balzan; Shoshana Bar-Nun; Antonio Barrientos; Peter Belenky; Marc Blondel; Ralf J Braun; Michael Breitenbach; William C Burhans; Sabrina Büttner; Duccio Cavalieri; Michael Chang; Katrina F Cooper; Manuela Côrte-Real; Vítor Costa; Christophe Cullin; Ian Dawes; Jörn Dengjel; Martin B Dickman; Tobias Eisenberg; Birthe Fahrenkrog; Nicolas Fasel; Kai-Uwe Fröhlich; Ali Gargouri; Sergio Giannattasio; Paola Goffrini; Campbell W Gourlay; Chris M Grant; Michael T Greenwood; Nicoletta Guaragnella; Thomas Heger; Jürgen Heinisch; Eva Herker; Johannes M Herrmann; Sebastian Hofer; Antonio Jiménez-Ruiz; Helmut Jungwirth; Katharina Kainz; Dimitrios P Kontoyiannis; Paula Ludovico; Stéphen Manon; Enzo Martegani; Cristina Mazzoni; Lynn A Megeney; Chris Meisinger; Jens Nielsen; Thomas Nyström; Heinz D Osiewacz; Tiago F Outeiro; Hay-Oak Park; Tobias Pendl; Dina Petranovic; Stephane Picot; Peter Polčic; Ted Powers; Mark Ramsdale; Mark Rinnerthaler; Patrick Rockenfeller; Christoph Ruckenstuhl; Raffael Schaffrath; Maria Segovia; Fedor F Severin; Amir Sharon; Stephan J Sigrist; Cornelia Sommer-Ruck; Maria João Sousa; Johan M Thevelein; Karin Thevissen; Vladimir Titorenko; Michel B Toledano; Mick Tuite; F-Nora Vögtle; Benedikt Westermann; Joris Winderickx; Silke Wissing; Stefan Wölfl; Zhaojie J Zhang; Richard Y Zhao; Bing Zhou; Lorenzo Galluzzi; Guido Kroemer; Frank Madeo
Journal:  Microb Cell       Date:  2018-01-01

Review 6.  Antifungal Compounds against Candida Infections from Traditional Chinese Medicine.

Authors:  Xin Liu; Zhiming Ma; Jingxiao Zhang; Longfei Yang
Journal:  Biomed Res Int       Date:  2017-12-28       Impact factor: 3.411

Review 7.  Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.

Authors:  Michael R Yeaman; Sabrina Büttner; Karin Thevissen
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

8.  Human Antimicrobial Peptide Hepcidin 25-Induced Apoptosis in Candida albicans.

Authors:  Ruei-Ching Chen; Chung-Yu Lan
Journal:  Microorganisms       Date:  2020-04-17

9.  The Synergistic Antifungal Effect and Potential Mechanism of D-Penicillamine Combined With Fluconazole Against Candida albicans.

Authors:  Yiman Li; Ping Jiao; Yuanyuan Li; Ying Gong; Xueqi Chen; Shujuan Sun
Journal:  Front Microbiol       Date:  2019-12-18       Impact factor: 5.640

10.  Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation.

Authors:  Shuai Dong; Hongxi Shi; Xintong Zhang; Xi Chen; Donghui Cao; Chuanbin Mao; Xiang Gao; Li Wang
Journal:  Int J Nanomedicine       Date:  2018-04-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.